Position
ALGERT GLOBAL LLC in Oric Pharmaceuticals, Inc.
Back to the book · All holders of ORIC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $182$0.01 → $0.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 40.5K | $331 | — | — | — | 0.0% |
| Q1 2026 | 136.3K | $1.73K | $0.01 | $182 | $1.21K | 0.0% |